Monday, September 29 is the PDUFA date for Relistor's sNDA (methylnaltrexone bromide) for the treatment of opioid-induced constipation (OIC). Salix (SLXP +5%) successfully appealed the FDA's CRL for the indication in July. (PGNX +0.6%)(NKTR +1.8%)(AZN -4%)(CBST +0.6%)(SGYP +3.1%)